Late myelotoxicity of high-dose chemotherapy according to the modified NHL-BFM-90 program in adult patients with diffuse large B-cell lymphoma

Late myelotoxicity of high-dose chemotherapy according to the modified NHL-BFM-90 program in adult patients with diffuse large B-cell lymphoma

Aim. To evaluate late myelotoxicity (MT) relate to high-dose chemotherapy (CT) according to the modified NHL-BFM-90 (mNHL-BFM-90) program in adult patients with diffuse large B-cell lymphoma (DLBCL). Subjects and methods. The results of a complex clinical, laboratory, and instrumental examination, i...

Full description

Bibliographic Details
Main Authors: E I Dorokhina, A U Magomedova, V N Dvirnyk, I V Galtseva, S A Glinkina, S M Kulikov, T N Obukhova, S K Kravchenko
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2016-07-01
Series:Терапевтический архив
Subjects:
late myelotoxicity
myelotoxicity
high-dose chemotherapy
mnhl-bfm-90
diffuse large b-cell lymphoma
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/31998/pdf

Internet

https://ter-arkhiv.ru/0040-3660/article/viewFile/31998/pdf

Similar Items